These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25277099)

  • 1. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.
    Marino AL; Evangelista AF; Vieira RA; Macedo T; Kerr LM; Abrahão-Machado LF; Longatto-Filho A; Silveira HC; Marques MM
    BMC Cancer; 2014 Oct; 14():739. PubMed ID: 25277099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
    Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
    RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
    BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
    Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
    Alunni-Fabbroni M; Majunke L; Trapp EK; Tzschaschel M; Mahner S; Fasching PA; Fehm T; Schneeweiss A; Beck T; Lorenz R; Friedl TWP; Janni W; Rack B;
    BMC Cancer; 2018 Feb; 18(1):141. PubMed ID: 29409452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
    Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O
    Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics prediction and experimental validation of a novel microRNA: hsa-miR-B43 within human CDH4 gene with a potential metastasis-related function in breast cancer.
    Rahimi A; Sedighi R; Emadi-Baygi M; Honardoost MA; Mowla SJ; Khanahmad H; Nikpour P
    J Cell Biochem; 2020 Feb; 121(2):1307-1316. PubMed ID: 31489987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.
    Wu X; Somlo G; Yu Y; Palomares MR; Li AX; Zhou W; Chow A; Yen Y; Rossi JJ; Gao H; Wang J; Yuan YC; Frankel P; Li S; Ashing-Giwa KT; Sun G; Wang Y; Smith R; Robinson K; Ren X; Wang SE
    J Transl Med; 2012 Mar; 10():42. PubMed ID: 22400902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
    Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
    Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study.
    Schrijver WA; van Diest PJ; ; Moelans CB
    Oncotarget; 2017 Jan; 8(2):3111-3123. PubMed ID: 27902972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
    Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
    Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
    Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
    Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
    Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
    Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
    Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L
    Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.